© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.

A nationally-published, award-winning journalist, Alex Biese joined the CURE team as an assistant managing editor in April 2023. Prior to that, Alex's work was published in outlets including the Chicago Sun-Times, MTV.com, USA TODAY and the Press of Atlantic City. Alex is a member of NLGJA: The Association of LGBTQ+ Journalists, and also performs at the Jersey Shore with the acoustic jam band Somewhat Relative.
A diagnosis of anal cancer can feel overwhelming, but understanding the disease is the first step toward effective management and recovery.
Receiving a diagnosis of anal cancer can feel overwhelming, but understanding the disease is the first step toward effective management and recovery. This guide serves as a foundational resource to help you navigate your journey and facilitate informed discussions with your oncology team.
Anal cancer is a disease in which malignant cells form in the tissues of the anus. While relatively rare compared to colorectal cancer, its incidence has been steadily increasing. The most common type is squamous cell carcinoma, which originates in the skin-like cells lining the anal canal.
The anus is the final segment of the gastrointestinal tract, and the cancer typically develops near the "pectinate line," where the lining changes from skin-type cells to rectal-type cells. Most cases are linked to the human papillomavirus (HPV), though other risk factors include smoking, a history of other cancers and a weakened immune system.
The diagnostic process is designed to confirm the presence of cancer and determine its stage, which indicates how far the disease has spread.
Treatment for anal cancer is highly effective, especially when caught early. Unlike many other cancers, the primary goal is often "organ preservation," meaning doctors try to treat the cancer without removing the anus.
The standard of care for most localized anal cancers is a combination of chemotherapy and radiation therapy (chemoradiation). Radiation uses high-energy beams to kill cancer cells, while chemotherapy drugs (usually Mitomycin-C and 5-Fluorouracil) make the cancer cells more sensitive to the radiation.
For advanced or metastatic anal cancer, immunotherapy drugs — which help your own immune system recognize and attack cancer cells — are increasingly being utilized.
Anal cancer survivors should remain vigilant through regular follow-up and routine screenings, as Dr. Rebecca Rhee told CURE in a recent interview.
Rhee works at Maimonides Medical Center, where she is a colorectal surgeon and program director of the general surgery residence.
“I would say the biggest thing, of course, with many cancers, is to not smoke,” she said. “Smoking is a universal thing that you should definitely stop to decrease your risk of cancer or recurrence. But other than that, general lifestyle things like eating a high fiber diet [can help], and some say avoiding red meat has provided some benefit.
“But even if you do all of those things perfectly, no smoking, no red meat, eating a high-fiber diet, there's still risk. That's why you get treatment and we do checkups. Surveillance to detect any possible recurrence, and, of course, to drive home the screening [is a key takeaway]. That's the real way we detect things and hopefully prevent cancers.”
A diagnosis of anal cancer is a significant life event, but modern treatments offer high cure rates and the possibility of maintaining a high quality of life. Education is your best tool for advocacy. As you meet with your oncologist, use this information to ask about your specific stage, the intent of your treatment, and what support services are available to you.
Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Related Content: